Literature DB >> 6469934

Naltrexone induction: psychologic and pharmacologic strategies.

H D Kleber, T R Kosten.   

Abstract

Attempts ot improve naltrexone retention during the induction and stabilization phases of treatment are described. During induction, street addicts appear to do better than postmethadone patients and to benefit more from counseling. Inpatient withdrawal and induction appear to be more successful than outpatient, but use of new techniques such as clonidine and clonidine/naltrexone may improve results in outpatients. Prolonged withdrawal symptoms and drug craving appear to contribute to the high dropout rate during stabilization. Pharmacologic and psychological methods of treatment, and future research strategies for these first two parts of naltrexone treatment, are summarized.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469934

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Authors:  Paolo Mannelli; Kathleen S Peindl; Tong Lee; Kamal S Bhatia; Li-Tzy Wu
Journal:  Curr Drug Abuse Rev       Date:  2012-03

2.  Opiate withdrawal: inpatient versus outpatient programmes.

Authors:  C Brewer
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

3.  A randomized trial of oral naltrexone for treating opioid-dependent offenders.

Authors:  Donna M Coviello; James W Cornish; Kevin G Lynch; Arthur I Alterman; Charles P O'Brien
Journal:  Am J Addict       Date:  2010 Sep-Oct

4.  A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.

Authors:  Maria A Sullivan; Adam Bisaga; Martina Pavlicova; Kenneth M Carpenter; C Jean Choi; Kaitlyn Mishlen; Frances R Levin; John J Mariani; Edward V Nunes
Journal:  Am J Psychiatry       Date:  2018-10-19       Impact factor: 18.112

5.  Long-acting injectable naltrexone for the management of patients with opioid dependence.

Authors:  Kimberly L Kjome; F Gerard Moeller
Journal:  Subst Abuse       Date:  2011-02-06

6.  Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Authors:  Paolo Mannelli; Kathleen S Peindl; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-06

Review 7.  Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.

Authors:  Adam Bisaga; Paolo Mannelli; Maria A Sullivan; Suzanne K Vosburg; Peggy Compton; George E Woody; Thomas R Kosten
Journal:  Am J Addict       Date:  2018-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.